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Conclusion and Perspectives
Objectives 
Measure of anaemia for each of the seven 
isolates, mean of 6 cows per isolate, 
irrespective of drug treatment.
Each of the 7 isolates behave as a classical, rather mildly pathogenic T.
congolense. Isolates from the first herd/location appear somewhat more
pathogenic than from the second herd/location. ZBZ-16 is somewhat
intermediate. This argue for the presence of at least two, maybe three,
genetically distinct strains. Treatments has no visible effect
Animal African trypanosomosis is arguably the main disease affecting livestock in inter-tropical Africa. Control methods are based on either vector control, or
chemotherapy. The latter mainly relies on two trypanocidal drugs, diminazene aceturate and isometamidium chloride, both introduced over sixty years ago, and the
combination of inadequate dosage used by farmers and the presence of low-quality drugs on the African market, has resulted in resistance to trypanocides in many
places.
The exact mechanism of drug resistance is still poorly understood, and thus no easy laboratory tests can be carried out to assess the resistance status of a given
isolate. For this reason, in vivo experimentation is still the rule. Some field studies have been conducted, but the necessary follow-ups are difficult to perform in field
conditions. In vivo assessment in laboratory conditions is thus often necessary to accurately measure the level of resistance. Although some tests have been
developed using rodents, the murine model has limits and assessing resistance in the target species, ruminants, is often necessary.
Drug-resistance has long been reported in the Zambêzia Province of Central Mozambique. A survey of the area was carried out in 2014 by Mulandane et al.1 as part of
the TRYRAC project. Numerous cases of resistance were observed, to either one or both trypanocides, but the actual parasites were not isolated and corresponding
strains were not characterized. Thus, whether strains are resistant to only one or both trypanocides and to what extent needs to be assessed in controlled conditions.
The aim of the study was to thoroughly assess the nature of the resistant strains. For this purpose, isolates were collected from field cattle that had reverted to
parasitemia status following treatment. The isolates were used to infect experimental cattle under laboratory condition, and the animals were then treated and
followed up.
This study had two distinct goals. On one hand, we wanted to assess the extent of resistance of some of the circulating isolates in the area, as this has implications for
control strategies. On the other hand, in the context of the quest for new trypanocides, well-characterized resistant field strains are an invaluable tool.
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Material and Methods
• Location: Nicoadala, Zambêzia, Mozambique
• Two cattle herds, one sampled in May 2016, the other in June 2016
• Cattle screened by Buffy-Coat technique in the field
• Positive animals treated with diminazene, resampled 7 days later
• Reverting animals treated with isometamidium, resampled after 7 days
• If still positive, blood shipped to Maputo. Seven isolates shipped
• Drugs used in the experiment courtesy of CEVA
• Shipped blood used to infect donor cattle at CB-UEM (one/isolate)
• Blood from each donor cattle used to infect 6 recipient cattle
• Cattle followed up daily for PCV, parasitaemia, temperature
• Weekly for weight gain, biweekly for clinical examination
• 3 cattle treated with diminazene, 3 with isometamidium 
• If reversion, swapping of treatment
• Strict GvLP (Good veterinary Laboratory Practice)
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• All stabilates behave in a similar way
• All are resistant to both drugs DIM & ISO
• Herd #1 isolates appear more resistant
than those of herd #2 (quicker reversion)
• In most cases, but not always, animals
become negative post-treatment
• Animals treated with DIM become
aparasitaemic quicker and revert late than
those treated with ISO
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• Male Nguni, 8 - 18 months, 120 to 280 kg
• No drastic weight loss, strains of low pathogenicity
• No effect of treatments on weight
• One out of the 48 experimental animals died
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Weight gain Drug-resistance
Number of days post-treatment before                             
negativation (3 animals per group)
Number of days post-treatment before 
repositivation (3 animals per group)
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period  (days)
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(= group 2)
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Herd #1
ZBZ-14 7 to 8 1-Never-1 1-3-1 3-3-3 3-3-3 7-always-4 12-10-11 7-5-5 12-10-8
ZBZ-15 8 to 9 2-2-1 1-1-1 3-3-2 3-3-2 4-7-9 7-12-Dead 5-5-5 4-6-5
ZBZ-16 9 to 13 1-2-1 1-1-1 3-3-3 3-3-4 4-9-8 6-14-3 5-5-5 12-12-12
ZBZ-17 7 to 9 Never-2-1 1-1-3 3-3-3 3-3-3 Always-7-7 7-9-8 5-5-7 10-12-14
Herd #2
ZBZ-18 12 for all 3-2-3 3-1-3 4-3-Never 3-3-6 8-6-5 10-15-15 8-8-always 13-12-14
ZBZ-19 12 for all 1-1-1 3-1-3 4-2-3 3-3-3 13-13-10 15-17-13 13-13-10 15-22-17
ZBZ-20 9 to 12 3-1-1 1-3-3 2-2-2 3-3-3 8-5-3 15-13-13 8-8-8 15-17-13
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• Herd #1 isolates have a longer prepatent period than those of Herd #2 (ZBZ-16 is again an exception)
• Animals clears their parasitaemia more rapidly with DIM than with ISO, from Herd #1 earlier than Herd #2
• Three animals, infected by distinct strains, never became negative, 2 after DIM treatment, 1 after ISO treatment
• All animals reverted post-treatment, but QUICKER:
• 1/ post-DIM treatment than post-ISO treatment
• 2/ if infected with isolates from Herd #1 (ZBZ-14 to ZBZ-17) than from Herd #2 (ZBZ-18 to ZBZ-20)
• 3/ after first treatment than after the secong, for both drugs
We reported here the systematic characterization under laboratory conditions of seven drug-resistant T. congolense field isolates from Zambêzia Province, Mozambique. This work furthers a
recent survey of the area, long considered as a hotspot for drug resistance. All isolates proved highly resistant to both the most commonly used drugs available on the market. Of particular
interest is the finding that parasites actually disappear from the bloodstream for up to two weeks post-treatment, giving the false impression of cure, but in all cases came back in full force.
These isolates show rather mild virulence and pathogenicity, and proved unable to readily infect rodents, arguing for a trade-off between the mechanisms of infectivity and resistance. This
may explain why livestock rearing continues is this endemic area despite the presence of seemingly an incurable disease.
In the current context of novel trypanocide drug discovery, these isolates could certainly prove instrumental in new molecule testing.
In the meantime, there is no doubt these findings raise a challenge in terms of disease control strategy in the area, and beyond. An integrated approach combining public awareness about
rational use of trypanocides with vector control should be implemented. Still, the area of origin of these isolates is rather circumscribed, and while it is unlikely to be an isolated case, a wider
survey should be considered. Likewise, the genetic relationship between these geographically connected isolates must be investigated.
